The negative correlation between Erdr1 and IL-18 expression has been shown [9], and therapeutic effects of Erdr1 on inflammatory diseases such as rheumatoid arthritis (RA), psoriasis, and rosacea have been determined [10,11,12]. The gene discussed is IL18; the disease is rheumatoid arthritis.